Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;126(7):1058-1062.
doi: 10.1016/j.ophtha.2019.01.031. Epub 2019 Feb 6.

Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series

Jenna May Kim  1 , Miguel A Materin  2 , Mario Sznol  3 , Harriet M Kluger  3 , Sarah Weiss  3 , Jessica Chow  1 , Kathleen Stoessel  1 , Ninani Kombo  1 , Lucian Del Priore  1 , Renelle Pointdujour-Lim  4
Affiliations

Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series

Jenna May Kim et al. Ophthalmology. 2019 Jul.
No abstract available

PubMed Disclaimer

References

    1. Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345–1356. - PMC - PubMed
    1. Hazarika M, Chuk MK, Theoret MR, et al. U.S. FDA approval summary: nivolumab for treatment of unresectable or metastatic melanoma following progression on ipilimumab. Clin Cancer Res. 2017;23:3484–3488. - PubMed
    1. Nguyen AT, Elia M, Materin MA, et al. Cyclosporine for dry eye associated with nivolumab: a case progressing to corneal perforation. Cornea. 2016;35:399–401. - PubMed
    1. Wong RK, Lee JK, Huang JJ. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of Vogt-Koyanagi-Harada syndrome. Retin Cases Brief Rep. 2012;6:423–426. - PubMed
    1. Maire C, Vercambre-Darras S, Devos P, et al. Metastatic melanoma: spontaneous occurrence of auto antibodies is a good prognosis factor in a prospective cohort. J Eur Acad Dermatol Venereol. 2013;27:92–96. - PubMed